Loading provider…
Loading provider…
Hematology & Oncology Physician in Boston, MA
NPI: 1356491237Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Dana-Farber Cancer Institute
dana-farber.org
HQ Phone
Get MD Jacob's Phone Numberphone_androidMobile
Get MD Jacob's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
MA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 73 | 121 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 60 | 110 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 39 | 39 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 17 | 45 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 13 | 16 |
Authors: Jennifer Suga, Primo Lara
Journal: Prostate Cancer Prostatic Dis
Publication Date: 2015-02-10
Updates in small cell lung cancer.
Authors: Jacob Sands
Publication Date: 2023-08-02
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
Authors: John Grecula, Rebecca Heist, Daniel Morgensztern, Robert Merritt, Albert Attia, Michael Bassetti, Gregory Kalemkerian, Apar Kishor Ganti, Nisha Mohindra, Billy Loo, Christine Hann, Afshin Dowlati, Marianna Koczywas, Chad Rusthoven, Rafael Santana Davila, Robert Downey
Journal: J Natl Compr Canc Netw
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Olaparib, DRUG: Etoposide, DRUG: Cediranib, DRUG: Cediranib Maleate
Lead Sponsor: Ascentage Pharma Group Inc.
Intervention / Treatment: DRUG: Paclitaxel, DRUG: APG-1252
Lead Sponsor: AstraZeneca
Collaborators: Medpace, Inc.
Intervention / Treatment: DRUG: Other